Grigoris Zoidis

1.2k citations

57 papers · 961 indexed · h-index 17

Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 9
Organic Chemistry top 5%
- Synthesis and Biological Evaluation 11
Hepatology top 10%
- Hepatitis C virus research 16
Epidemiology top 10%
- Hepatitis B Virus Studies 11
- Trypanosoma species research and implications 10
- Influenza Virus Research Studies 8
Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 16
Molecular Biology
- Pharmacological Receptor Mechanisms and Effects 7

Co-authors: Nicolas Kolocouris George Fytas Erik De Clercq Lieve Naesens John M. Kelly Christos Fytas George B. Foscolos John E. Tavis
Cited by: Biochemistry Organic Chemistry Hepatology
Journals: SHILAP Revista de lepidopterología (1 paper)International Journal of Molecular Sciences (1 paper)Journal of Medicinal Chemistry (1 paper)
Partner nations: Greece United Kingdom United States

In The Last Decade

Grigoris Zoidis

55 papers receiving 942 citations

Peers

Countries citing papers authored by Grigoris Zoidis

Since Specialization

Citations

This map shows the geographic impact of Grigoris Zoidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grigoris Zoidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grigoris Zoidis more than expected).

Fields of papers citing papers by Grigoris Zoidis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grigoris Zoidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grigoris Zoidis. The network helps show where Grigoris Zoidis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Grigoris Zoidis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Grigoris Zoidis Line = papers co-authored together Grigoris Zoidis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery of N-Hydroxypyridinedione-Based Inhibitors of HBV RNase H: Design, Synthesis, and Extended SAR Studies International Journal of Molecular Sciences ·Dea Chotzalli,Vasiliki Pardali,Helen Walden,Dimitrios Perivolaris,Dimitrios Moianos,Maria Makri,Antonios Drakopoulos,Erofili Giannakopoulou,Razia Tajwar,Molly E. Woodson,John E. Tavis,Grigoris Zoidis	2025	0
2	Discovery and Characterization of Uracil Derivatives Targeting the Set-and-Ring Domain of UHRF1 Journal of Chemical Information and Modeling ·Ifigeneia Akrani,Danai Driva,Efstratios Tsakalidis,Nandini Mozumdar,Danai Mavridi,Anthi Panara,Kalypso Epiphaniou,Maria Chalkiadaki,A.F. Wright,Maria Halabalaki,Angeliki Tsoka,Grigoris Zoidis,Constantinos E. Vorgias,Duncan Sproul,Evagelos Gikas,Skirmantas Kriaučionis,Emmanuel Mikros,Vassilios Myrianthopoulos	2025	0
3	A New Era of Muscarinic Acetylcholine Receptor Modulators in Neurological Diseases, Cancer and Drug Abuse Pharmaceuticals ·Helena Tsimpili,Grigoris Zoidis	2025	2
4	Novel Pyrazino[1,2-a]indole-1,3(2H,4H)-dione Derivatives Targeting the Replication of Flaviviridae Viruses: Structural and Mechanistic Insights Viruses ·Erofili Giannakopoulou,Ifigeneia Akrani,George Mpekoulis,Efseveia Frakolaki,Marios Dimitriou,Vassilios Myrianthopoulos,Niki Vassilaki,Grigoris Zoidis	2024	2
5	Efficacy and in vitro pharmacological assessment of novel N -hydroxypyridinediones as hepatitis B virus ribonuclease H inhibitors Antimicrobial Agents and Chemotherapy ·Molly E. Woodson,Heather S. Walden,M. Abdul Mottaleb,Maria Makri,Georgia‐Myrto Prifti,Dimitrios Moianos,Vasiliki Pardali,Grigoris Zoidis,John E. Tavis	2024	1
6	Targeting Metalloenzymes: The “Achilles’ Heel” of Viruses and Parasites Pharmaceuticals ·Dimitrios Moianos,Georgia‐Myrto Prifti,Maria Makri,Grigoris Zoidis	2023	7
7	Novel Lipophilic Hydroxamates Based on Spirocarbocyclic Hydantoin Scaffolds with Potent Antiviral and Trypanocidal Activity Pharmaceuticals ·Vasiliki Pardali,Erofili Giannakopoulou,George Mpekoulis,Vassilina Tsopela,G. Panos,Martin C. Taylor,John M. Kelly,Niki Vassilaki,Grigoris Zoidis	2023	2
8	Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors Pharmaceuticals ·Jehad Hamdy,Nouran Emadeldin,Mostafa M. Hamed,Efseveia Frakolaki,Sotirios Katsamakas,Niki Vassilaki,Grigoris Zoidis,Anna K. H. Hirsch,Mohammad Abdel‐Halim,Alireza Abadi	2022	2
9	Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors Viruses ·Tamer Nasr,Ahmed M Aboshanab,George Mpekoulis,Antonios Drakopoulos,Niki Vassilaki,Grigoris Zoidis,Khaled A. M. Abouzid,Wafaa A. Zaghary	2022	4
10	Design and Synthesis of Novel Symmetric Fluorene-2,7-Diamine Derivatives as Potent Hepatitis C Virus Inhibitors Pharmaceuticals ·Mai H. A. Mousa,Nermin S. Ahmed,Kai Schwedtmann,Efseveia Frakolaki,Niki Vassilaki,Grigoris Zoidis,Jan J. Weigand,Alireza Abadi	2021	3
11	The Triazole Ring as a Privileged Scaffold for Putative Antifungals: Synthesis and Evaluation of a Series of New Analogues ChemMedChem ·Grigoris Zoidis,Eftichia Kritsi,Paulina Lecinska,Marija Ivanov,Panagiotis Zoumpoulakis,Marina Sokóvić,Marco Catto	2020	15
12	A multi-technique analytical approach for impurity profiling during synthesis: The case of difluprednate Journal of Pharmaceutical and Biomedical Analysis ·Nicolette Sammut Bartolo,Grigoris Zoidis,Evagelos Gikas,Dimitra Benaki,Victor Ferrito,Anthony Serracino‐Inglott	2020	2
13	Symmetric Anti-HCV Agents: Synthesis, Antiviral Properties, and Conformational Aspects of Core Scaffolds ACS Omega ·Alaa R. S. Leila,Mai H. A. Mousa,Efseveia Frakolaki,Niki Vassilaki,Ralf Bartenschlager,Grigoris Zoidis,Mohammad Abdel‐Halim,Alireza Abadi	2019	5
14	Expanding the chemical space of anti‐HCV NS5A inhibitors by stereochemical exchange and peptidomimetic approaches Archiv der Pharmazie ·Triveena M. Ramsis,Shereen E. Abdel Karim,Niki Vassilaki,Efseveia Frakolaki,Ahmed A. M. Kamal,Grigoris Zoidis,Nermin S. Ahmed,Alireza Abadi	2018	6
15	Quinolino[3,4- b ]quinoxalines and pyridazino[4,3- c ]quinoline derivatives: Synthesis, inhibition of topoisomerase IIα, G-quadruplex binding and cytotoxic properties European Journal of Medicinal Chemistry ·Fausta Palluotto,Alice Sosic,Odra Pinato,Grigoris Zoidis,Marco Catto,Claudia Sissi,Barbara Gatto,Angelo Carotti	2016	33
16	Design and synthesis of bioactive 1,2-annulated adamantane derivatives Organic & Biomolecular Chemistry ·Grigoris Zoidis,Andrew Tsotinis,Nicolas Kolocouris,John M. Kelly,S. Radhika Prathalingam,Lieve Naesens,Erik De Clercq	2008	32
17	Design and synthesis of bioactive adamantane spiro heterocycles Bioorganic & Medicinal Chemistry Letters ·Nicolas Kolocouris,Grigoris Zoidis,George B. Foscolos,George Fytas,S. Radhika Prathalingham,John M. Kelly,Lieve Naesens,Erik De Clercq	2007	84
18	Heterocyclic rimantadine analogues with antiviral activity Bioorganic & Medicinal Chemistry ·Grigoris Zoidis,Christos Fytas,Ioannis Papanastasiou,George B. Foscolos,George Fytas,Elizaveta Padalko,Erik De Clercq,Lieve Naesens,Johan Neyts,Nicolas Kolocouris	2006	109
19	The novel GABA adamantane derivative (AdGABA): design, synthesis, and activity relationship with gabapentin Bioorganic & Medicinal Chemistry ·Grigoris Zoidis,Ioannis Papanastasiou,Yannis Dotsikas,Alejandro Sandoval,Raquel Gouvêa dos Santos,Z. Papadopoulou‐Daifoti,Alexander Vamvakides,Nicolas Kolocouris,Ricardo Felix	2005	37
20	New 2-(1-adamantylcarbonyl)pyridine and 1-acetyladamantane thiosemicarbazones–thiocarbonohydrazones: cell growth inhibitory, antiviral and antimicrobial activity evaluation Bioorganic & Medicinal Chemistry Letters ·Antonios Kolocouris,Kostas Dimas,Christophe Pannecouque,Myriam Witvrouw,George B. Foscolos,George Stamatiou,George Fytas,Grigoris Zoidis,Nicolas Kolocouris,Graciela Andreï,Robert Snoeck,Erik De Clercq	2002	55

About Grigoris Zoidis

Grigoris Zoidis is a scholar working on Hepatology, Biochemistry and Infectious Diseases, having authored 57 papers that have together received 961 indexed citations. Recurring topics across this work include Hepatitis C virus research (16 papers), HIV/AIDS drug development and treatment (16 papers), Hepatitis B Virus Studies (11 papers), Synthesis and Biological Evaluation (11 papers), Trypanosoma species research and implications (10 papers), Eicosanoids and Hypertension Pharmacology (9 papers), Influenza Virus Research Studies (8 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). The work is most often cited by research in Biochemistry (129 citations), Organic Chemistry (498 citations) and Hepatology (115 citations). Grigoris Zoidis has collaborated with scholars based in Greece, United Kingdom and United States. Frequent co-authors include Nicolas Kolocouris, George Fytas, Erik De Clercq, Lieve Naesens, John M. Kelly, Christos Fytas, George B. Foscolos, John E. Tavis, Ioannis Papanastasiou and Johan Neyts. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact